The Role of JAK2 in Myeloproliferative Diseases Diagnosis
Biomolecular and Health Science Journal · 2018
DOI: 10.20473/bhsj.v1i2.9831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecular and Health Science Journal, 2018. Verfasst von Yudith Annisa Ayu Rezkitha und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Janus Kinase 2 (JAK2) plays an important role in mediating transduction signal of hematopoiesis, including in the pathogenesis of Myeloproliferative diseases (MPD). Various studies have been carried out to identify the position of aleles in tyrosine encoding mutations. Although the effect of JAK2 mutations is still not fully understood, the discovery of these mutations might be able to differentiate the types of polycythaemia vera, essential thrombocytemia, and primary myelofibrosis with malignant abnormalities. WHO has revised the MPD diagnosis criteria following this finding. This review will discuss the role of JAK2.
Zitieren
APA
Rezkitha, Y. A. A., Bintoro, S. U. Y., & Ashariati, A. (2018). The Role of JAK2 in Myeloproliferative Diseases Diagnosis. Biomolecular and Health Science Journal. https://doi.org/10.20473/bhsj.v1i2.9831
Vancouver
Rezkitha YAA, Bintoro SUY, Ashariati A. The Role of JAK2 in Myeloproliferative Diseases Diagnosis. Biomolecular and Health Science Journal. 2018. doi:10.20473/bhsj.v1i2.9831
BibTeX
@article{Rezkitha2018,
author = {Rezkitha, Yudith Annisa Ayu and Bintoro, S. Ugroseno Yudho and Ashariati, Ami},
title = {The Role of JAK2 in Myeloproliferative Diseases Diagnosis},
journal = {Biomolecular and Health Science Journal},
year = {2018},
doi = {10.20473/bhsj.v1i2.9831}
}
EUVIMED